Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors

BACKGROUND: Controversy exists as to whether low-dose aspirin use may give benefit in primary prevention of cardiovascular (CV) events. We hypothesized that the benefits of aspirin are underevaluated. METHODS: We investigated 12,123 Caucasian patients presenting to hospital with acute coronary syndr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EClinicalMedicine
Auteurs principaux: Bugiardini, Raffaele, Pavasović, Saša, Yoon, Jinsung, van der Schaar, Mihaela, Kedev, Sasko, Vavlukis, Marija, Vasiljevic, Zorana, Bergami, Maria, Miličić, Davor, Manfrini, Olivia, Cenko, Edina, Badimon, Lina
Format: Artigo
Langue:Inglês
Publié: Elsevier 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599315/
https://ncbi.nlm.nih.gov/pubmed/33150322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100548
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires